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        Background: Craniospinal radiotherapy faces 
technical challenges which are due to the sensitivity 
of the location in which the gross tumor is, and to 
organs at risk around planning target volume. Using 
modern treatment planning systems causes a           
reduction in the complexities of the treatment          
techniques. The most effective method to assess the 
dosimetric accuracy and the validity of the software 
used for treatment planning is to investigate the            
radiotherapy and treatment planning by means of a 
anthropomorphic Rando phantom which was used 
here for treatment planning and practical dosimetry 
for craniospinal radiotherapy. Studying the absorbed 
dose by the organs at risk was the secondary        
objective discussed in this paper. Materials and 
Methods: Treatment planning in craniospinal            
radiotherapy was done using CorePlan 3D treatment 
planning software. Radiotherapy was administered on 
a anthropomorphic Rando phantom and practical 
dosimetry was done using GR-200 TLDs. Varian          
Clinac 2100C/D was used for radiotherapy. Results: 
The absorbed dose by regions of interest was             
separately calculated for treatment planning and  
radiotherapy. Except the conjunction areas of the 
cranial and spinal radiation fields, the difference 
among the results was not more than 5%. Full         
comparison of the results for each part has been       
presented. Conclusion: The comparison the results of 
practical dosimetry and treatment planning software 
supports the validity of CorePlan treatment planning 
system. Also analysis of the absorbed dose through 
organs at risk showed that the absorbed dose by  
organs at risk have an acceptable value with respect 
to tolerance dose of these organs. The only unaccept-
able result was related to thyroid. Iran. J. Radiat. Res., 
2011; 9(3): 151­158 
 
        Keywords: Craniospinal radiotherapy, rando        
phantom, thermoluminescence dosimetry, treatment         
planning.  
 
INTRODUCTION 
 
Medulloblastoma is one of the most  
common diseases of central nervous system 
tumors for which craniospinal radiotherapy 
is used for treatment purposes (1, 2). Treat-
ment planning and radiotherapy of the          
central nervous system tumors are facing 
technical challenges which are imposed by 
the sensitivity of gross tumor location and 
the normal tissues and organs at risk 
around the planning target volume (PTV). 
The treatment targets in craniospinal radio-
therapy consists the entire brain and the 
spine, and the organs at risk are the eye 
lens, heart, cribriform plate, thyroid and 
testis (2). Craniospinal radiotherapy causes 
detrimental changes in the white matter of 
children’s brain. Consequently this change 
leads to a reduction in the patient’s learning 
and mental skills at the learning age (3). It is 
common among these patients to suffer from 
disorder in the function of the endocrine 
glands (like thyroid) and as a consequence 
of unwanted received doses by these glands. 
So, it might be the testis (or ovary) that is 
exposed to scattered radiation from spinal 
cord of the patient (4). New techniques like 
radiotherapy coupled with moving the con-
junction of radiation fields (5), or conformity 
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of cerebral and spinal radiation fields using 
geometric calculations (1) may reduce the 
harmful results of radiotherapy. At present, 
to administer craniospinal radiotherapy, 
photon beam is used for cerebral PTV, and 
electron and/or photon beam for spinal PTV. 
Some of treatment centers, however, have 
presented the results drawn from using pro-
ton beam (6). Using modern instruments to 
treatment planning and radiotherapy        
reduces the complexities of this treatment 
technique and ensures uniformity of dosage 
in treatment PTV (7). The most effective way 
to evaluate the accuracy of dosimetry and 
validity of the treatment planning software 
is to investigate the radiotherapy in anthro-
pomorphic Rando Phantom that has been 
used in this research, to compare the results 
of treatment planning system (TPS) and 
practical dosimetry. Evaluation of the        
absorbed dose by organs at risk has been 
discussed as a secondary objective.  
 
MATERIALS AND METHODS 
 
Dosimetric phantom 
RANDO Phantom provides the detailed 
mapping of dose distribution that is essen-
tial for evaluating radiotherapy treatment 
plans. A Rando phantom produced by the 
phantom laboratory (USA) was used for          
radiotherapy. This phantom was a skeleton 
of a man with 173.5 cm of height and 73.5 
Kg of weight in which isosionat plastic was 
used for the soft tissues, having the normal 
human skeletal system (8). The Phantom 
was divided longitudinally into 33 slices 
each 2.5 cm and all of them used for radio-
therapy. Each slice had holes in it to sit the 
dosimeter for measuring the absorbed dose 
in radiotherapy and radiography research. 
Each slice had two pins at its edges; the         
different slices of Phantom were bound up 
together by those pins, in order to have a 
full phantom. To prevent the slices from  
being torn out and avoiding air gap produc-
tion among them, the Phantom was         
surrounded by an assembly composed of two 
wooden plates placed at the head of the first 
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slice and the end of the last one (9). 
 
Calibration of applied dosimeters and            
dosimetric method 
GR-200 Thermoluminescence crystals 
produced by PTW Company (Germany) 
which included LiF (Mg, Cu, P) in the form 
of tablets with the diameter of 4.5 mm and 
thickness of 0.8 mm were used in this         
research (10). 40 dosimeters were used for the 
different areas inside the phantom and 4 
dosimeters for controlling the background 
radiation. To use these dosimeters, at first 
the efficiency correction coefficient (ECC) of 
each TLD's was calculated and then the 
calibration curve of the applied TLDs was 
produced. To produce the calibration curve, 
38 dosimeters were divided into several 
groups, and each group was ex-posed to a 
certain amount of gamma rays produced by 
60Co machine. The calibration curve of ap-
plied dosimeters was as follow in figure 1. 
The Fimel TLD reader produced by 
PTW Company was used to read the TLDs. 
The liquid nitrogen pressure was1.1 bars 
inside it. Every TLD was exposed to tem-
perature at two stages. At the first stage, 
the exposition lasted for 6  seconds in 155cG. 
This was done to stabilize the TLD                 
responses. At the second stage, which was 
the dosimeter reading stage, every TLD was     
exposed to heat for 35 seconds at 260cG of        
temperature. 
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Figure1.  The calibration curve of used TLDs. 
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Planning and dosimetry in craniospinal radiotherapy  
Treatment planning 
The Phantom was scanned by Somatom 
CT Scan machine Produced by Siemens 
Company (Germany) in prone position. The 
applied CT system was spiral, and it was 
able to scan with Smart mA feature. 
For treatment planning, the CT images 
of the phantom were input to the CorePlan 
3D treatment Planning software in Dicom 
format. This software has been produced in 
Seoul C&J Inc, (Korea) and was able to 
show the isodose curves in all CT plans. In 
this software, photon dose is performed by 
Collapsed Cone Convolution algorithm (in 
adaptive and non-adaptive way) and 
Equivalent TAR (ETAR) algorithm, and 
electron dose calculations by Hogstrom      
Pencil Beam algorithm. These methods 
could count tissue inhomogeneity in a           
reasonable manner (11, 12), and the absorbed 
dose in different areas, therefore, can be 
precisely calculated. In treatment planning, 
6 MV X-ray photons were used for irradia-
tion of the brain and upper spine (extending 
from the first   cervical vertebrae down to 
the first lumbar vertebrae), and 18 MV X-
ray photons were used for the lower spine 
(extending from the second lumbar vertebra 
down to second sacral vertebrae). In order to 
avoid overlap between cranial and upper 
spine fields, the couch was given an angle of 
4 degree and 9 for the collimators of cranial 
fields (figure 2). The treatment targets in 
the treatment planning included the brain, 
upper and lower spines, Organs at risk like 
the lens, thyroid, the heart and testis. The 
reference points were set at PTV centers of 
brain, upper and lower spine. The radiation 
fields were configured in a way that the          
absorbed dose in these points would be 50 
cGy.  
 
Set-up for irradiation (treatment) 
 Varian linear accelerator 2100C/D 
model (USA), was used for craniospinal         
radiotherapy. This accelerator is able to  
produce X rays with energies equal to 6 MV 
and 18 MV and electron beams with          
energies equal to 6 MeV, 9 MeV, 12 MeV, 15 
MeV and 18 MeV. For radiotherapy, the 
phantom was in prone position. (Another 
position in which the phantom can be laid is 
supine (13)) In order to avoid overlap between 
cranial and upper spine fields, the conjunc-
tion of orthogonal fields was adjusted by 
changing the position of the couch and the 
collimators of the cranial fields. The couch 
was given 4 degrees of angle (clockwise) for 
the left lateral cranial field and 4 degrees 
(anticlockwise) for the right lateral cranial 
one. The cranial field collimators were also 
rotated 9 degrees (clockwise). Because of the 
long length of the spinal cord, two spinal 
fields were used to entirety cover the spinal 
PTV and achieve dose unifor-mity across the 
spinal cord (14). The upper spine was              
considered to be extending from the first 
cervical vertebrae down to the first lumbar 
vertebrae, and the lower spine from the         
second lumbar vertebra down to the second 
sacral vertebrae. Like the treatment plan-
ning stage, for the upper spine 6 MV and for 
the lower spine 18 MV X-ray was used. 
Monitor unit of the machine was adjusted to 
deliver 50 cGy to ICRU reference point. For 
irradiation of the brain and spinal cord, 
source to axis distance (SAD), and source to 
surface distance (SSD) technique were used, 
respectively. 
40 Thermoluminescence dosimeters 
were used in practical dosimetry. These         
dosimeters were planted inside the brain, at 
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Figure 2.  Adjustment of the radiation fields in treatment 
planning. 
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the conjunction of cranial radiation fields 
and upper spine radiation field, thyroid, 
heart and testis. 
 
RESULTS  
 
The results of treatment planning 
The results of treatment planning           
system were divided into quantitative and 
qualitative groups. In the qualitative group, 
isodose curves in the axial slices, where 
treatment targets and organs at risk have 
been located, were presented. Treatment 
targets and organs at risk have been         
separately margined in those slices. Isodose 
curves are differentiated by different colors. 
Doses associated with each color have been 
presented at the right top of each image. 
Figures 3, 4, 5, 6 and 7 are related to brain 
PTV and eye lens, thyroid, heart, conjunc-
tion site of cranial and upper spine fields 
and testis, respectively.  
Figure 3. Treatment plan and isodose curves for brain and 
eye lenses. 
Figure 4. Treatment plan and isodose curves for thyroid. 
Figure 5.  Overlap of fields in treatment planning and 
isodose curves in this  region. 
Figure 6.  Treatment plan and isodose curves for heart. 
Figure 7.  position of testis in treatment planning. 
In the quantitative group, dose volume 
histograms (DVH) associated with the      
treatment targets and the organs at risk 
have been displayed in figure 8. The large 
amount of dosimetric data that must have 
been analyzed, while evaluating the treat-
ment plan had prompted the development of 
new methods of condensing and presenting 
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Planning and dosimetry in craniospinal radiotherapy  
the data in more easily understandable for-
mats. One of such data reduction tools has 
been the DVH. The diagram was very useful 
for calculation of average absorbed dose and 
dose uniformity in target volume (2). Each 
color in every diagram indicated a target or 
an organ at risk. Each organ associated with 
each color has been presented at the right 
top of the image. It could be seen that brain 
PTV, upper and lower spine had received 
uniform dose, hence the absorbed dose by 
volume of organs at risk was nonuniform. 
Using isodose and DVH curves related 
to each organ, one can calculate the average 
absorbed dose in the treatment targets and 
organs at risk. The following table (table 1) 
shows the absorbed dose in these areas. 
 
Figure 8.  DVH curves of treatment targets and the organs at risk in treatment planning. 
Table 1.  Relative absorbed dose in different regions resulted from  tratment planning system (to delivery of 50 cGy to the refrence 
point). 
Relative absorbed dose (%)  Interested area 
102 Brain 
 90 Overlap area of cranial and 
upper spine fields 
28 Left eye 
34 Right eye 
48 Thyroid 
46 Heart 
 150 Overlap area of upper and 
lower spine fields 
Very small Testis 
Iran. J. Radiat. Res., Vol. 9, No. 3, December 2011 155 
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The results of Practical Dosimetery 
In order to determine the absorbed dose, 
at the practical stage, the dosimeters were 
located inside the organs of interest (figure 
9), and the average dose coming out of all 
these dosimeters in the organ were calcu-
lated. For elimination of background effects, 
4 TLDs were used during radiotherapy.  
The results of the practical dosimetry in 
the Phantom have been presented in the 
following table (table 2). It must be men-
tioned that the reported absorbed doses in 
different regions, both treatment planning 
and radiotherapy, were normalized to           
reference dose (50 cGy), to provide better 
comparison between the results. 
Comparing the quantitative results
(figure 10), it was concluded that, except the 
conjunction areas of the cranial and spinal 
radiation fields, there is no difference higher 
than 5%, and the results of practical         
dosimetry were consistent with those by the 
treatment planning system and the conse-
quent with the validity of CorePlan TPS. 
Figure 9.  Location TLDs in heart region for practical          
dosimetry 
Figure 10. Comparision between the practical dosimetry 
and treatment planning results. 
Interested 
area 
Minimum 
relative 
dose (%) 
Maximum 
relative 
dose (%) 
Average   
relative 
dose (%) 
standard 
deviation 
Brain  102  114  106  0/13± 
Overlap area 
of cranial and 
upper spine 
fields 
  
  
88 
  
  
  
147 
  
 
140 
  
  
  
0/22± 
Thyroid  10  86  48  0/22± 
Heart  36  64  44  ±0/17 
Overlap area 
of upper and 
lower spine 
fields 
  
136 
  
  
  
150 
  
142 
  
  
14/0± 
TesƟs Very small  - - - 
Table 2.  The results of  practical dosimetry in regions of interest (to delivery of 50 cGy to the refrence point) 
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DISCUSSION 
 
The only difference in the results was 
observed in the conjunction areas of the      
cranial and spinal radiation fields which has 
been left a matter of further discussion. This 
might have been caused by errors made in 
the practical stage, including those caused 
by radiation field adjustments, inaccuracy 
in positioning dosimeters in the conjunction 
of cerebral and upper spinal fields, inherent 
errors of the used TLDs, the errors of TLD 
reader machine, or a defect in the software 
while calculating the dose at the conjunction 
of cerebral and upper spinal fields. Due to 
the intense dose gradient in these regions, 
the occurred errors in positioning of TLDs 
could have an important role in incoherence 
of results. 
Due to the lack of any holes in spinal 
cord, eye lens and cribriform plate, it was 
not possible to measure the dose in these 
regions using TLD. Moreover, since the 
holes were way distant from the skin, meas-
uring the absorbed dose by the latter was 
impossible too. 
In spite of the fact that using two spinal 
radiation fields would lead to better dose 
distribution across the spinal cord, it caused 
an overlap area in the conjunction of these 
fields; thus, the absorbed dose at the       con
-junction increases. To reduce this effect, 
the conjunction of these radiation fields was 
being changed during the treat-ment (5, 15). 
Moreover, for spinal radiotherapy, electron 
beam could be used instead of the photon 
beam. This made a better separation of the 
normal tissues from spinal PTV (2, 16). The 
inhomogeneity of the tissue, however, can 
have much more effects on the isodose 
curves of the electron beam and may caused 
nonuniform distribution of dose across the 
spinal cord, and leave this area underdosed 
(2) In craniospinal radiotherapy for Medul-
lobalstoma, the total dose adminis-tered to 
the cerebral PTV (excluding the boost dose 
administered to posterior fossa) was          
between 3500 to 4000 cGy and the total         
administered dose to the spinal PTV is         
between 3000 and 3500 cGy (17). Considering 
the total administered dose to the brain was 
3600 cGy and that which is administered to 
the spinal cord is 3200 cGy, the total        
absorbed dose by the thyroid gland was 
1664 cGy at the end of the radiotherapy. As 
it is shown in the reference (2), the thyroid 
disorders caused by the direct radiation of 
ray may vary, which tends to be considered 
in terms of thyroid stimulation hormone 
(TSH). Regardless of thyroxin being increas-
ing or decreasing, the cases of disorder tend 
to be occur when the absorbed dose by the 
whole gland is between 1500 and 5000 cGy. 
Although the absorbed dose by this organ 
does not exceed 5000 cGy, it fell in the 
variation range of the thyroid performance. 
Generally, this is a matter of debate,        
because the literature on radiotherapy has 
not elaborated on the tolerance dose of thy-
roid. The total dose absorbed by the heart 
was 1872 cGy which is quite acceptable in 
comparison with the tolerance dose of this 
organ that is 4000 cGy (2). The testis          
receives a lesser dose. So, these glands        
received a lower dose of scattered rays due 
to the scattering of X-ray photons across  
spinal cord, although they are located out-
side the lower spine radiation field. This  
result was deduced from testis DVH in           
figure 10, too. The results of this research 
have a good accordance with the research by 
Hood and his colleagues (13). One of the aims 
of the mentioned research was the valida-
tion of ADAC Pinnacle treatment planning 
in craniospinal radiotherapy. For evaluation 
of TPS performance, a Rando phantom had 
been used and dosimetric measurements 
during treatment had been performed using 
thermoluminescent dosimeters (TLDs). 
Other research in this field is related to 
Mollazade and colleagues (18). In this        
research the validity and accuracy of 
RtDoseplan treatment planning software 
has been evaluated. The results of their         
research showed that the difference between 
TPS and dosimetric measurements has been 
3% which is similar to the result yielded by 
the present research. 
Planning and dosimetry in craniospinal radiotherapy  
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